Whether or not they smoke, most young people don’t share the tobacco companies’ view that New Zealand’s new smokefree measures will reduce their autonomy or limit their freedoms.
Academic rigor, journalistic flair
Articles on tobacco industry
Displaying all articles
Even if the new smokefree legislation did cause some temporary extra illegal trade in tobacco, the best response would still be better law enforcement and border control.
Water and energy prices are fixed, so why not do the same with cigarettes?
When news outlets also publish so-called ‘native advertising,’ their journalistic reputations suffer – and their news coverage shies away from the companies that paid for the ads.
Skeptics may make demands for absolute certainty to undermine science and delay action. Critiques may not be in the interest of advancing science and public health, but by someone with an agenda.
New Zealand will hold the world’s first national referendum on legalising recreational use of cannabis in September. It must learn from mistakes in implementing earlier drug law reforms.
The Chinese National Tobacco Corporation is expanding its international markets through subsidiaries. Is the world ready for tobacco companies sponsoring or supporting schools?
They’re effective – and popular.
History is complex and multi-dimensional. Any response to what happened in the past should reflect this.
It is time governments made corporations pay for the harm they cause.
Research shows that a higher excise tax rate on tobacco would result in a decrease in the number of people who smoke.
Economic tactics play a big part in a habit that’s hard to break.
New research shows just how bad tobacco farming can be for the environment and for farmers.
The World Trade Organisation (WTO) has reportedly backed Australia’s laws on plain tobacco packaging implemented from December 2012. The apparent decision marks the end of the last of three cases brought…
Tobacco tax increases in Australia that will see a packet of cigarettes costing A$40 may discourage smoking, but will end up having unintended consequences for poorer smokers, new research shows.
Classing e-cigarettes as quit smoking aids could help rebrand the tobacco industry as a legitimate player in health policy. Here’s why we should be concerned.
Food, drug and other companies often sponsor research in the hope it might produce results favourable to their products. How can we ensure such research remains independent?
Top contributors
-
Professor of Public Health/Director, Tobacco Control Research Group, University of Bath
-
Senior Lecturer (Associate Professor) in Business Economics, University of Bath
-
Professor of Public Health, University of Otago
-
Adjunct Senior Lecturer, Centre for Primary Health Care and Equity, University of New South Wales, UNSW Sydney
-
Emeritus Professor in Public Health, University of Sydney
-
PhD candidate, University of Edinburgh, The University of Edinburgh
-
Professor of Public Health, University of Otago
-
Assistant Professor, London School of Hygiene & Tropical Medicine
-
Reader, Global Public Health Unit, The University of Edinburgh
-
Chair professor, University of Sydney
-
Researcher in Conservation and Agriculture, University of Leeds
-
Research fellow, Pacific Institute on Pathogens, Pandemics and Society, Simon Fraser University
-
Professor of Human Rights, University of Bristol
-
Research Associate, University of Bath
-
Senior lecturer and Health Economist, School of Economics and Finance, Wits University, University of the Witwatersrand
